ロード中...
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
Abstract Background The efficacy and safety of lapatinib plus capecitabine (LC or LX) versus trastuzumab plus chemotherapy in patients with HER-positive metastatic breast cancer who are resistant to trastuzumab is unknown. Methods We retrospectively analyzed data from breast cancer patients who bega...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2020-03-01
|
| シリーズ: | BMC Cancer |
| 主題: | |
| オンライン･アクセス: | http://link.springer.com/article/10.1186/s12885-020-6639-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|